Signup Crypto ETF Stocks News

Carbon Revolution Sets Date for Fiscal 2024 Earnings Release and Conference Call - Carbon Revolution ( NASDAQ:CREV )

GEELONG, Australia, May 12, 2025 ( GLOBE NEWSWIRE ) -- Carbon Revolution plc CREV ( the "Company" ) , a Tier 1 automotive supplier and the world's leading manufacturer of innovative, lightweight carbon fiber wheels, announced today it will hold a conference call to discuss its fiscal 2024 ...

Source: www.benzinga.com
May 12, 2025 | 20:30:00
Category: News

Cellectis Reports Financial Results for the First Quarter 2025

NEW YORK, May 12, 2025 ( GLOBE NEWSWIRE ) -- Cellectis ( the "Company" ) ( Euronext Growth: ALCLS - NASDAQ: CLLS ) , a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today provided financial results for the first ...

Source: www.globenewswire.com
May 12, 2025 | 20:30:00
Category: News

Carbon Revolution Sets Date for Fiscal 2024 Earnings Release and Conference Call

GEELONG, Australia, May 12, 2025 ( GLOBE NEWSWIRE ) -- Carbon Revolution plc ( Nasdaq: CREV ) ( the "Company" ) , a Tier 1 automotive supplier and the world's leading manufacturer of innovative, lightweight carbon fiber wheels, announced today it will hold a conference call to discuss its fiscal ...

Source: www.globenewswire.com
May 12, 2025 | 20:30:00
Category: News

Tandy Leather Factory Reports First Quarter 2025 Results

FORT WORTH, Texas, May 12, 2025 ( GLOBE NEWSWIRE ) -- Tandy Leather Factory, Inc. ( Nasdaq: TLF ) today announced the Company's financial results for the first fiscal quarter of 2025.

Source: www.globenewswire.com
May 12, 2025 | 20:30:00
Category: News

Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq

MORRISTOWN, N.J., May 12, 2025 ( GLOBE NEWSWIRE ) -- Hepion Pharmaceuticals, Inc. ( NASDAQ:HEPA ) , a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatohepatitis ( "NASH" ) , hepatocellular carcinoma ( "HCC" ) , and other chronic liver diseases ...

Source: www.globenewswire.com
May 12, 2025 | 20:30:00
Category: News

Cellectis Reports Financial Results for the First Quarter 2025 - Cellectis ( NASDAQ:CLLS )

Lasme-cel ( UCART22 ) Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025 Eti-cel ( UCART20x22 ) Phase 1 study in relapsed or refractory B-cell non-Hodgkin lymphoma ( r/r NHL ) ongoing with readout expected in late 2025

Source: www.benzinga.com
May 12, 2025 | 20:30:00
Category: News

KBRA Affirms Ratings for Heritage Commerce Corp - Heritage Commerce ( NASDAQ:HTBK )

SAN JOSE, Calif., May 12, 2025 ( GLOBE NEWSWIRE ) -- Heritage Commerce Corp HTBK ( the "Company" ) , parent company of Heritage Bank of Commerce ( the "Bank" ) , announced today that Kroll Bond Rating Agency, LLC ( "KBRA" ) affirmed the Company's senior unsecured debt rating of BBB+, the ...

Source: www.benzinga.com
May 12, 2025 | 20:30:01
Category: General

Marijuana Stock Movers For May 12, 2025 - Aurora Cannabis ( NASDAQ:ACB ) , Aleafia Health ( OTC:ALEAF )

Flower One Hldgs FLOOF shares closed up 9900.00% at $0.0001 Target Group CBDY shares closed up 17.65% at $0.00 FLUENT CNTMF shares closed up 13.05% at $0.05 Canopy Gwth CGC shares closed up 9.92% at $1.46 Corbus Pharmaceuticals CRBP shares closed up 9.92% at $7.16

Source: www.benzinga.com
May 12, 2025 | 20:30:09
Category: Markets

$100 Invested In Motorola Solutions 15 Years Ago Would Be Worth This Much Today - Motorola Solutions ( NYSE:MSI )

Motorola Solutions MSI has outperformed the market over the past 15 years by 8.12% on an annualized basis producing an average annual return of 19.72%. Currently, Motorola Solutions has a market capitalization of $68.94 billion.

Source: www.benzinga.com
May 12, 2025 | 20:30:17
Category: Trading

Rigetti Stock Sinks After Q1 Revenues Miss Estimates: Details - Rigetti Computing ( NASDAQ:RGTI )

Rigetti reports earnings of 13 cents per share, which beat the analyst consensus estimate of losses of 6 cents. Quarterly revenue comes in at $1.47 million, which missed the analyst consensus estimate of $2.55 million.

Source: www.benzinga.com
May 12, 2025 | 20:31:34
Category: News

© Natavest 2025 - 2026